Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 420

Similar articles for PubMed (Select 21875844)

1.

Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.

Katapodi MC, Northouse L, Pierce P, Milliron KJ, Liu G, Merajver SD.

Oncol Nurs Forum. 2011 Sep;38(5):572-81. doi: 10.1188/11.ONF.572-581.

PMID:
21875844
2.

Psychometric testing of the decisional conflict scale: genetic testing hereditary breast and ovarian cancer.

Katapodi MC, Munro ML, Pierce PF, Williams RA.

Nurs Res. 2011 Nov-Dec;60(6):368-77. doi: 10.1097/NNR.0b013e3182337dad.

3.

Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience.

Wagner Costalas J, Itzen M, Malick J, Babb JS, Bove B, Godwin AK, Daly MB.

Am J Med Genet C Semin Med Genet. 2003 May 15;119C(1):11-8.

PMID:
12704633
4.

Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testing.

Lodder L, Frets PG, Trijsburg RW, Klijn JG, Seynaeve C, Tilanus MM, Bartels CC, Meijers-Heijboer EJ, Verhoog LC, Niermeijer MF.

Am J Med Genet A. 2003 Jun 15;119A(3):266-72.

PMID:
12784290
5.

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM.

J Natl Cancer Inst. 1997 Jan 15;89(2):148-57.

6.

Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.

Katapodi MC, Northouse LL, Milliron KJ, Liu G, Merajver SD.

Psychooncology. 2013 Jun;22(6):1336-43. doi: 10.1002/pon.3139. Epub 2012 Jul 24.

PMID:
22826208
7.

BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.

McInerney-Leo A, Biesecker BB, Hadley DW, Kase RG, Giambarresi TR, Johnson E, Lerman C, Struewing JP.

Am J Med Genet A. 2005 Mar 1;133A(2):165-9.

PMID:
15633195
9.

The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer and the frequency of occurrence of these tumours in their relatives.

Skasko E, Paszko Z, Niwińska A, Kwiatkowska E, Kruczek A, Pieńkowski T.

Eur J Gynaecol Oncol. 2004;25(4):470-4.

PMID:
15285306
10.

Five families living with hereditary breast and ovarian cancer risk.

Norris J, Spelic SS, Snyder C, Tinley S.

Clin J Oncol Nurs. 2009 Feb;13(1):73-80. doi: 10.1188/09.CJON.73-80.

PMID:
19193551
11.
12.

Uptake of predictive testing among relatives of BRCA1 and BRCA2 families: a multicenter study in northeastern Spain.

Sanz J, Ramón y Cajal T, Torres A, Darder E, Gadea N, Velasco A, Fortuny D, López C, Fisas D, Brunet J, Alonso MC, Balmaña J.

Fam Cancer. 2010 Sep;9(3):297-304. doi: 10.1007/s10689-009-9313-1.

PMID:
20091130
13.

Diagnostic genetic testing for hereditary breast and ovarian cancer in cancer patients: women's looking back on the pre-test period and a psychological evaluation.

Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Legius E.

Genet Test. 2004 Spring;8(1):13-21.

PMID:
15140370
14.
15.

Cancer surveillance behaviors in women presenting for clinical BRCA genetic susceptibility testing.

Loescher LJ, Lim KH, Leitner O, Ray J, D'Souza J, Armstrong CM.

Oncol Nurs Forum. 2009 Mar;36(2):E57-67. doi: 10.1188/09.ONF. E57-E67.

PMID:
19273395
16.

Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.

Bluman LG, Rimer BK, Berry DA, Borstelmann N, Iglehart JD, Regan K, Schildkraut J, Winer EP.

J Clin Oncol. 1999 Mar;17(3):1040-6.

PMID:
10071299
17.

Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing.

Lodder L, Frets PG, Trijsburg RW, Tibben A, Meijers-Heijboer EJ, Duivenvoorden HJ, Wagner A, van Der Meer CA, Devilee P, Cornelisse CJ, Niermeijer MF.

Eur J Hum Genet. 2001 Jul;9(7):492-500.

18.

Cancer prevention and screening practices among women at risk for hereditary breast and ovarian cancer after genetic counseling in the community setting.

Morgan D, Sylvester H, Lucas FL, Miesfeldt S.

Fam Cancer. 2009;8(4):277-87. doi: 10.1007/s10689-009-9242-z. Epub 2009 Apr 4.

PMID:
19347608
19.

Factors associated with decisions about clinical BRCA1/2 testing.

Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B.

Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1251-4.

20.

Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.

Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Legius E.

Am J Med Genet A. 2003 Jan 1;116A(1):11-9.

PMID:
12476445
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk